![]() |
![]() |
(±)-1-(a-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride (1:1) 1-[2-DIMETHYL AMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANONE HYDROCHLORIDE (+) cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride (1:1) Efectin Efexor Effexor MFCD03658865 N,N-dimethyl-2-p-methoxyphenyl-2-(1-hydroxycyclohexyl) ethylamine hydrochloride RTECS GV?8872760 Venlafaxine HCl VENLAFAXINEHCL Venlafaxinehydrochloride/VenlafaxineHCl Venlaffaxine HCL VenlfaxineHydrochloride Venlift
Hazard Codes:?Xi
Risk Statements 36/37/38?
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-37/39
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.?
S37/39:Wear suitable gloves and eye/face protection.
?Venlafaxine hydrochloride , its cas register number is 99300-78-4. It also can be called (+/-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride ; (RS)-1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride ; Effexor .It is a?white crystalline powder.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 1071ug/kg (1.071mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) SKIN AND APPENDAGES (SKIN): SWEATING: OTHER |
Journal of Toxicology, Clinical Toxicology. Vol. 35, Pg. 211, 1997. |
man | TDLo | oral | 32mg/kg/9W-I (32mg/kg) | BEHAVIORAL: HEADACHE BEHAVIORAL: WITHDRAWAL |
Medical Journal of Australia. Vol. 169, Pg. 91, 1998. |
women | LDLo | oral | 168mg/kg (168mg/kg) | BEHAVIORAL: COMA CARDIAC: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Medical Journal of Australia. Vol. 169, Pg. 445, 1998. |
women | LDLo | oral | 235mg/kg/12D- (235mg/kg) | LUNGS, THORAX, OR RESPIRATION: "FIBROSIS, FOCAL (PNEUMOCONIOSIS)" GASTROINTESTINAL: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA |
Journal of Analytical Toxicology. Vol. 20, Pg. 266, 1996. |
women | TDLo | oral | 94500ug/kg/9W (94.5mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" SKIN AND APPENDAGES (SKIN): SWEATING: OTHER |
Annals of Pharmacotherpy. Vol. 33, Pg. 1009, 1999. |
women | TDLo | oral | 315mg/kg/30W- (315mg/kg) | BEHAVIORAL: WITHDRAWAL GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING |
Medical Journal of Australia. Vol. 169, Pg. 91, 1998. |
women | TDLo | oral | 360mg/kg/17W- (360mg/kg) | BEHAVIORAL: WITHDRAWAL SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION |
Medical Journal of Australia. Vol. 169, Pg. 91, 1998. ? |
Eye irritation, Category 2
Pictogram(s) | ![]() |
---|---|
Signal word | Warning |
Hazard statement(s) | H319 Causes serious eye irritation |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P280 Wear protective gloves/protective clothing/eye protection/face protection. |
Response | P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists: Get medical advice/attention. |
Storage | none |
Disposal | none |
none
![]() |
![]() |
![]() |